MAEL can be involved in ESCC progression by regulation of AKT1/RelA/IL8 signaling to recruit Myeloid-Derived Suppressor Cells (MDSCs) to tumor sites. The gene discussed is CXCL8; the disease is esophageal squamous cell carcinoma.